The primary route of human exposure is consumption of contaminated foods (Huwe and Larsen 2005) ; in the past, occupational exposures were significant (Gustavsson and Hogstedt 1997) . Populations near polluted toxic waste dump sites have demon strated learning, memory, and behavioral abnormalities in children exposed in utero and via breast milk (Schantz et al. 2003) . Therefore, previous studies have defined at-risk populations, primarily based on their exposure to PCB-contaminated foods or their proximity to PCB-contaminated sites.
Evidence for PCB-induced neuro toxicity includes studies of exposed human populations worldwide (Grandjean et al. 2001; Guo et al. 1997; Gustavsson and Hogstedt 1997; Jacobson 1997, 2003; Nakai et al. 2004 ). These studies consistently show learning, memory, and behavioral deficits that extend into school age (Jacobson and Jacobson 2003; Vreugdenhil et al. 2004 ) and increased neuro degenerative diseases (Petersen et al. 2008; Schantz et al. 2001) . The greatest risk is to children exposed in utero and through consumption of contaminated breast milk (Guo et al. 2004; Schantz et al. 2003) . Studies in non human primates (Rice 2000; Schantz et al. 1989 ) and rodents (Gilbert et al. 2000; Roegge and Schantz 2006) have confirmed the unique susceptibility of the developing central nervous system (CNS) to PCBs.
In the present study we used a previously developed mixture of eight PCBs that included coplanar and non coplanar PCBs prevalent in food, human tissue, and breast milk (Curran et al. 2011) ; these PCBs were chosen because they have previously been implicated in develop mental neuro toxicity.
Single-congener studies offer utility when searching for mechanisms, but they are less satisfactory at modeling human exposures.
Coplanar PCBs are aryl hydrocarbon receptor (AHR) ligands (Poland and Glover 1977) , and maternal levels of hepatic cytochrome P450 1A2 (CYP1A2) influence the amount of AHR ligand reaching the embryo or fetus (see Dragin et al. 2006 and references therein). Moreover, humans are known genetically to exhibit > 12-fold variability in AHR affinity and > 60-fold differences in hepatic CYP1A2 basal uninduced levels (Nebert et al. 2004 ). Thus, we adminis tered the PCB mixture to mice representing extremes for variation in high-versus poor-affinity AHR and high versus absent CYP1A2 basal levels.
In characterizing these mice (Curran et al. 2011) , we examined effects of the PCB mixture [given on gestational day (GD) 10.5 and postnatal day (PND) (-/-) ]. These lines were evaluated for PCB effects on birth weight, growth, immuno suppression, AHR activation, and CYP1A1 and CYP1A2 mRNA levels in tissues of the mother, embryo, fetus, and pup; the concentrations of each of the PCB congeners in these tissues were measured at five time points. We also confirmed important genetic differences in the abovementioned parameters (Curran et al. 2011) . In that study (Curran et al. 2011) , administration of the mixture to the mother at GD10.5 and PND5 resulted in continuous AHR activation in the high-affinity-Ahr b1 embryo, fetus, and weanling. GD10.5 to PND20 is the period of rodent brain develop ment that most closely matches brain develop ment in the second to third trimesters of human develop ment (Clancy et al. 2007 ).
Materials and Methods
Chemicals. Noncoplanar PCB congeners 105, 118, 138, 153, and 180 and coplanar PCB congeners 77, 126, and 169 [see Supplemental Material,  (Liang et al. 1996) . Backcrossing produced geno types that express > 99.8% B6. Animals were housed in a vivarium accredited by the Association for Assessment and Accreditation of Laboratory Animal Care; the animals were treated humanely and with regard for alleviation of suffering.
Breeding. Nulliparous females 3-5 months of age (body weight, 20-25 g) were used for all matings. The morning when a vaginal plug was found was considered GD0.5, and plug-positive females were removed from the breeding cages. Pregnant females were housed individually with pups until weaning on PND28.
Dosing of animals. Pregnant females were given the PCB mixture by gavage on GD10.5 and PND5; these time points were chosen to ensure continual AHR activation throughout lactation and were based on our previous study (Curran et al. 2011) . Controls were gavaged with an equivalent volume of corn oil vehicle (15 mL/kg). Dosing was delayed until GD10.5 to avoid interfering with implantation and to minimize neo natal lethality (Curran et al. 2006) .
Behavior. Animals were tested in groups from all three geno types (PCB-treated vs. corn-oil-treated controls). One male and one female per litter were tested (16-20/group) beginning on PND60: week 1, elevated zero maze, locomotor activity, and acoustic startle response (ASR) with prepulse inhibition (PPI); week 2, novel-object recognition; week 3, Morris water maze (MWM) cued; week 4, MWM hidden acquisition; week 5, MWM hidden reversal; week 6, MWM hidden shift; week 7, locomotor activity with (+) methamphetamine (1 mg/kg) challenge. Mice were placed in the apparatus for 30 min to habituate them to the environment; they were then removed, injected with meth amphetamine, and returned to the apparatus for an additional 120 min. All tests were performed during the light portion of the light:dark cycle.
Elevated zero maze. The apparatus for this test is a circular runway (105-cm diameter), 72-cm above the floor with a 10-cm path divided into equal quadrants; two opposite quadrants have 28-cm walls, and two remaining opposite quadrants have 1.3-cm acrylic curbs. Mice were video taped for 5 min. Time in open and numbers of head dips and zone crossings were scored (Shepherd et al. 1994) .
Locomotor activity. For evaluation of locomotor activity, mice were tested for 1 hr in arenas that measured 41 × 41 cm and had 16 LED photocells in the x-and y-planes (Accuscan Instruments, Columbus, OH).
ASR-PPI. For this test, we used an SR-LAB apparatus (San Diego Instruments, San Diego, CA) with 5-min acclimation, followed by a 4 × 4 Latin square of four trial types repeated three times: no stimul us, startle signal (SS), 74-dB prepulse + SS, or 76-dB prepulse + SS. The intertrial interval was 8 sec, and the interstimulus interval was 70 msec. The signal was a mixed-frequency white noise burst (120 dB sound pressure level for 20 msec). Peak response amplitudes (V max ) were analyzed.
Novel object recognition. For evaluation of novel object recognition, mice were habituated to arenas (91-cm diameter) for 2 days, followed by 2 days of exposure to two objects (10 min/day). On the test day new objects were presented until 30 sec of observation accrued; 1 hr later, the familiar (copy) and novel object were both presented, until 30 sec of observation accrued (up to 10 min).
MWM. The tank for the MWM was 122 cm in diameter (Vorhees and Williams 2006) . Testing was as follows: day 1 consisted of six cued trials with the start and platform fixed; for days 2-6, there were two trials per day with random start and finish positions (curtains were closed to block visual cues). The 10-cm platform contained an orange ball 10 cm above the surface. Mice received three phases of hidden-platform testing, four trials per day for 6 days, with 30-sec probe trial on day 7 [see Supplemental Material, Table S2 (http://dx.doi.org/10.1289/ehp.1002965)]. Each phase used a smaller platform (10, 7, or 5 cm). Data were analyzed for latency, cumulative distance, path length, speed on platform trials and crossovers, average distance, and quadrant preference on probe. For additional information, see Supplemental Material, p. 2.
Long-term potentiation (LTP). We measured LTP using a MED64 multi electrode array (Alpha Med Sciences, Kadoma, Japan) (Shimono et al. 2002) on parasagittal hippocampal sections (350 μm) of PND30-35 mice. Paired pulses were delivered to CA1, and excitatory postsynaptic potentials (EPSPs) were recorded until stable. Slope of EPSPs was recorded for 90 min after a theta burst [tetanus = 100 Hz in 10 bursts (4 pulses/ burst) delivered at a burst frequency of 5 Hz for 2 sec]. Sections were analyzed in duplicate for each animal.
Monoamine neuro transmitter assay. Neurotransmitters [dopamine (DA) and its metabolite 3,4-dihydroxyphenylacetic acid, and serotonin and its metabolite 5-hydroxyindole acetic acid] were analyzed as previously described (Graham et al. 2011) . See Supplemental Material, p. 4 (http://dx.doi. org/10.1289/ehp.1002965) for details.
Corticosterone assay. Corticosterone levels were measured using an immuno assay kit (Octeia Corticosterone EIA kit AC-14F1; IDS Inc., Fountain Hills, AZ) following the manufacturer's protocol. Blood was collected in heparinized tubes and centrifuged at 2,500 relative centrifugal force for 5 min at 4°C, and plasma was stored at -80°C. All samples were run in duplicate, and corti costerone levels were calculated by comparison with a standard curve ranging from 0 to 133 ng/mL. Statistical analyses. Behavioral data were analyzed using mixed-linear analysis of variance (ANOVA) with repeated measures or by analysis of covariance (ANCOVA) using SAS software (version 9.2; SAS Institute Inc., Cary, NC). Results were considered statistically significant if p < 0.05, as analyzed by slice-effect ANOVAs and biochemical data by two-way ANOVA followed by Holm-Sidak post hoc comparisons.
Results
Body weight. Mice were weighed on PND60 and PND100; we observed no differences in body weight among treatment groups or geno types.
Elevated zero maze. PCB-treated Ahr d _ Cyp1a2(+/+) mice exhibited fewer head dips Figure 1A ) argues against this interpretation. Novel object recognition. PCB-treated Ahr b1 _Cyp1a2(-/-) was the only group showing significant deficits in novel object recognition ( Figure 1D ). PCB-treated Ahr b1 _ Cyp1a2(-/-) mice spent a lower percentage Latency (sec)
Latency (sec)
Control PCBs of time exploring the novel object compared with controls, suggesting that PCB-treated Ahr b1 _Cyp1a2(-/-) mice are less able to remember the familiar object and distinguish it from the new object. Locomotor activity. Decreases in PCBtreated rodent locomotor habituation have been reported (Eriksson 1997) . Regardless of treatment, Ahr b1 _Cyp1a2(-/-) mice were more active than the other geno types (Figure 2A ). Treatment differences were significant only for PCB-treated Ahr b1 _Cyp1a2(+/+) mice, compared with controls during the middle (20-, 40-, and 50-min) intervals.
ASR with PPI. The ASR-PPI test measures baseline startle response and its attenuation when preceded by a lower-decibel tone preceding it (prepulse). We found no differences in PPI in PCB-treated mice compared with controls, regardless of AHR geno type. Untreated Ahr b1 _Cyp1a2(-/-) mice had significantly reduced amplitude in ASR than did untreated controls of either of the other two geno types. PCB-treated Ahr b1 _Cyp1a2(-/-) mice exhibited decreased ASR ( Figure 2B ) compared with controls, as did the PCBtreated Ahr b1 _Cyp1a2(+/+) mice. In contrast, PCB-treated Ahr d _Cyp1a2(+/+) mice showed a trend (p = 0.08) toward increased ASR. PCB exposure has been linked to hearing loss; however, hearing deficits cannot explain these results because all mice exhibited ASR after the 74-and 76-dB prepulses.
MWM, cued platform. We observed no differences among the groups on day 1 (data not shown). Data for days 2 and 3 showed that PCB-treated Ahr b1 _Cyp1a2(-/-) mice took longer to reach the platform (greater latency) than did controls ( Figure 3A ). Further analysis revealed that this difference was attributable to slower swimming in PCB-treated Ahr b1 _Cyp1a2(-/-) mice on days 2 and 3 ( Figure 3B ), with no significant differences thereafter.
MWM, hidden platform. Latency, path length, and cumulative distance showed the same pattern; therefore, only cumulative distance is shown (Figure 4) . During all phases (acquisition, reversal, and shift), PCB-treated mice swam more slowly than did controls regardless of geno type. Therefore, we analyzed the data without and with adjustment for swim speed. Among the Ahr b1 _Cyp1a2(+/+) mice, PCB treatment affected performance during reversal learning ( Figure 4C,D) . With and without adjustment for speed, the PCBtreated mice showed improved performance (i.e., shorter cumulative distances to reach the goal), compared with controls. Among Ahr d _Cyp1a2(+/+) mice, PCB treatment was associated with minor differences: on day 3 of acquisition, PCB-treated mice showed shorter cumulative distance than did controls, and on day 5 PCB-treated mice had increased cumulative distance, which is significant with covariate adjustment (Figure 4A-D) .
The most striking effects occurred among Ahr b1 _Cyp1a2(-/-) mice (Figure 4) : The PCB-treated group showed impaired acquisition, reversal, and shift learning without adjustment for speed ( Figure 4A ,C,E). During acquisition, adjustment for speed reduced the magnitude and number of days that were significant but did not eliminate the deficit ( Figure 4B ). During reversal, adjustment for speed eliminated and reversed the deficit on days 1 and 2 ( Figure 4D ), indicating that swimming ability of the PCB-treated group might account for this effect. Similarly, during the shift, impairment in the PCB-treated group was eliminated after adjustment for swim speed ( Figure 4F ). Variations were seen between day and sex when they were included in the analyses along with geno type and treatment. PCB treatment was associated with better performance in both Cyp1a2(+/+) lines but with poorer performance in the Ahr b1 _Cyp1a2(-/-) line. Analysis showed that PCB treatment primarily caused differences among females [see Supplemental Material, Figure S1 (http:// dx.doi.org/10.1289/ehp.1002965)].
MWM trial failure. We also analyzed trial failure, which represents the proportion of trials that the mouse reached the 60-sec time limit and had to be removed. Analyses of these data ( Figure 5A -C) demon strate that only PCB-treated Ahr b1 _Cyp1a2(-/-) mice showed increased rates of failure on all three phases (acquisition, reversal, and shift), compared with controls.
MWM memory. All measures of probetrial performance (a measure of spatial memory because the platform has been removed) showed similar patterns; therefore, only average distance to target is presented in Figure 5D -F. We observed no differences on the acquisition probe ( Figure 5D ). On reversal probe, PCB-treated Ahr b1 _Cyp1a2(+/+) mice had significantly shorter distances to the platform site than did controls ( Figure 5E ). On shift probe, PCB-treated Ahr b1 _Cyp1a2(-/-) mice had significantly longer distances to the platform site than did controls, consistent with the trial failure data for this group ( Figure 5F ).
Methamphetamine challenge. We retested locomotor activity after a dose of the positive entantiomer (+) of methampheta mine (an indirect dopaminergic agonist). Before the challenge, we observed no differences among Figure S2B ,C (http://dx.doi.org/10.1289/ehp.1002965)]; however, among Ahr b1 _Cyp1a2(+/+) mice, PCB-treated animals were again significantly more active than controls (see Supplemental Material, Figure S2A ). After methamphetamine, mice in all groups showed the typical pattern of hyperactivity. No significant differences as a function of PCB treatment were seen among the Ahr d _Cyp1a2(+/+) mice (see Supplemental Material, Figure S2B ). Among Ahr b1 _Cyp1a2(-/-) mice (see Supplemental Material, Figure S2C ), we observed small differences in the PCB-treated group compared with controls. Because of differences in predrug activity in PCB-treated Ahr b1 _ Cyp1a2(+/+) mice (see Supplemental Material, Figure S2A , left), the post challenge analysis used the last 10 min of the pre challenge data as a covariate; ANCOVA indicated only one significant PCB-related difference (during the 80-min test interval; data not shown).
LTP. Another way to examine whether PCB treatment alters neuro plasticity is LTP induction. LTP in the CA1 region of the hippocampus is a cellular correlate of spatial learning and memory (Pavlides et al. 1991) . We restricted our analysis to Ahr b1 _Cyp1a2(+/+) vehicle-treated controls and the two PCBtreated groups that showed the greatest difference in MWM tests compared with control wild-type, PCB-treated Ahr b1 _Cyp1a2(-/-) and PCB-treated Ahr b1 _Cyp1a2(+/+) mice.
In the presence or absence of CYP1A2, PCB treatment significantly impaired LTP in the CA1 region compared with Ahr b1 _ Cyp1a2(+/+) controls (Figure 6 ), confirming that PCB treatment early in life alters neuroplasticity irrespective of the Cyp1a2 geno type.
Monoamine neuro transmitter levels. We observed no differences in mono amine levels in hippocampus or prefrontal cortex among geno types, regardless of treatment. In the neo striatum, DA levels were lower in PCBtreated versus control Ahr d _Cyp1a2(+/+) mice (p < 0.01); DA levels were significantly lower in PCB-treated Ahr b1 _Cyp1a2(-/-) than in PCBtreated Ahr b1 _Cyp1a2(+/+) mice (p < 0.01). For the latter, DA levels were lower in PCBtreated than in control Ahr d _Cyp1a2(+/+) mice (p < 0.01); DA levels were significantly lower in PCB-treated Ahr b1 _Cyp1a2(-/-) than in PCBtreated Ahr b1 _Cyp1a2(+/+) mice (p < 0.01; data available upon request).
We observed no structural abnormalities or differences in size, shape, or appearance of the hippocampus, prefrontal cortex, or neostriatum in hematoxylin-and-eosin-stained sections (data not shown).
Plasma corticosterone levels. No PCBrelated differences were found in plasma corticosterone levels (data not shown).
Discussion
Since the earliest report of cognitive dysfunction in Yusho and Yu-Cheng PCB poison victims (Abe et al. 1975) , there have been attempts to identify the individual congeners responsible for various toxic end points reported, including neuro toxicity (Ryan et al. 1990 ). The controversy remains unsettled: Some argue that only non coplanar PCBs have neuro toxic effects (Rice 1999) , whereas others report neuro toxic effects after exposure to coplanar PCBs, dioxins, and related AHR ligands (Amin et al. 2000; Seegal et al. 2005) .
Others have used commercial mixtures (Branchi et al. 2005; Chishti et al. 1996) or laboratory-developed mixtures (Hamm et al. 2003; Kostyniak et al. 2005) . However, even a mixture having the same name (e.g., Aroclor 1254) and expected chemical composition can vary from batch to batch (Kodavanti et al. 2001 ). The controversy is best summed up in a review by Ulbrich and Stahlmann (2004) , in which the authors documented attempts to model PCB-induced neuro toxicity in rodents. Wide variation in dosing concentrations, routes of adminis tra tion, and animal models has resulted in variability and results that are not always reproducible.
Data from the present study suggest that both AHR and CYP1A2 play important roles in response to an environmentally relevant mixture of PCB congeners (three coplanar and five non coplanar). The presence of high-affinity AHR decreases the amount 
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of exposure of offspring to coplanar congeners via inducible P450-mediated detoxication pathways (Nebert et al. 2004) , whereas maternal CYP1A2 sequesters coplanar PCBs, thereby diminishing the level of their exposure (Dragin et al. 2006) .
Our behavioral phenotyping uncovered significant differences at many levels involving the effects of develop mental PCB exposure associated with the Ahr and Cyp1a2 genotypes. Genetic background influences behavior (Crawley et al. 1997; Jacobson and Cryan 2007) , but differences in genetic background were decreased as contributing factors in the present study because all lines were backcrossed at least eight generations into B6 mice. Nonetheless, we found significant geno type effects independent of treatment for several tests, including the elevated zero maze, locomotor activity, ASR, and MWM. For example, among controls, Ahr b1 _Cyp1a2(+/+) mice showed fewer zone crossings in the elevated zero maze than did mice of the other geno types ( Figure 1C ). In addition, Ahr b1 _Cyp1a2(-/-) control mice exhibited longer latencies in the MWM (Figure 3 ) and higher overall levels of locomotor activity ( Figure 2A ) compared with controls of the other geno types.
Effects of PCB were evident in all tests, reinforcing what had been previously reported with PCB congeners. Interestingly, PCBtreated Ahr b1 _Cyp1a2(+/+) mice showed improved MWM performance in reversal ( Figure 4 ) and reversal probe (Figure 5 ), suggesting that coplanar-PCB-mediated AHR activation can have beneficial effects on selected aspects of learning. Previous studies have shown that rats exposed to 2,3,7,8-tetrachloro dibenzo-p-dioxin (TCDD) or coplanar PCBs make fewer errors in the radial-arm maze (Schantz et al. 1996; Seo et al. 2000; Widholm 2003) . The results in the present study support the finding that AHR plays an important role in mammalian CNS develop ment. Indeed, even with no apparent ligand-binding properties, AHR analogs in Caenorhabditis elegans (Qin and PowellCoffman 2004) and Drosophila (Crews and Brenman 2006) have been demonstrated to be associated with neuronal develop ment.
The behavioral deficits that we observed in the present study are consistent with the hypothesis that maternal hepatic CYP1A2 protects against PCB-induced develop mental neuro toxicity in offspring. In a previous study, Dragin et al. (2006) reported that maternal hepatic CYP1A2 and maternal hepatic human CYP1A2 (in place of the mouse analogous protein) provided protection from TCDDinduced cleft palate and hydronephrosis, and that absence of maternal CYP1A2 increased sensitivity to TCDD-induced birth defects. Another study (Curran et al. 2011) showed that maternal hepatic CYP1A2 protected offspring of mothers that received the same PCB mixture used in the present study from PCB-induced toxicity.
Only PCB-treated Ahr b1 _Cyp1a2(-/-) mice showed impairment in novel object recog nition ( Figure 1D ). These data are consistent with human studies (Jacobson et al. 1985; Kilburn 2000) , one of which showed deficits on the Fagan test of novel object recog nition (Jacobson et al. 1985) . As noted above, all human populations display a > 60-fold gradient ranging from low to high CYP1A2 basal levels; however, no human study has specifically assessed CYP1A2 pheno type as a risk factor for PCB neuro toxicity. During MWM testing, we also uncovered spatial learning and memory deficits associated with PCB exposure. PCB-treated Ahr b1 _Cyp1a2(-/-) mice took longer to learn the cued platform than did untreated controls (Figure 3 ) but only on days 2 and 3, indicating that effects were not a result of treatment-related visual impairment that might interfere with spatial learning during hidden platform testing. PCB-treated Ahr b1 _Cyp1a2(-/-) mice showed deficits in all three phases of hidden-platform testing (Figures 4 and 5) . These deficits were more pronounced as the difficulty of the task increased, but some differences between treated and control mice were reduced when we adjusted the cumulative distance parameter for swim speed. This occurred despite the fact that the cumulative distance parameter is less affected by swim speed than is latency (time needed to find platform), suggesting that covariate analysis (with swim speed as the covariate) may have over adjusted this index, perhaps because swim speed and learning were affected simultaneously, making the separation of the two factors imperfect. Most important, the failure rate in PCB-treated Ahr b1 _Cyp1a2(-/-) mice was significantly higher than in all other groups, arguing against an effect mediated by swim speed alone.
In addition, relative to controls, the baseline ASR was lower in PCB-exposed Ahr b1 _ Cyp1a2(-/-) and Ahr b1 _Cyp1a2(+/+) mice but not in Ahr d _Cyp1a2(+/+) mice, indicating that both AHR and CYP1A2 are critical for proper develop ment of this defensive reflex. In a study of Long-Evans rats, Goldey et al. (1995) reported that develop mental Aroclor 1254 exposure through PND21 reduced ASR at PND24 but not during adulthood. In a follow-up experiment, a decreased ASR at PND23 was replicated, but the ASR was Figure 6 . LTP results shown as the percentage of baseline (mean ± SE). The inset shows the EPSP slope in CA1 region slices; the solid line represents the baseline response, and the dashed line represents the response 30 min following tetanus [prolonged membrane response to the electrical stimulation; 100 Hz in 10 bursts (four pulses per burst) delivered at a burst frequency of 5 Hz for 2 sec]. No additional units are possible on the axes because the absolute amplitudes and times vary because of the different specific cells being measured (graphs in the inset represent the wave form, not the exact values of any given curve). No differences between the groups were seen within treatments for response to stimulus or baseline response (n = 6, with all mice originating from separate litters). ANOVA showed an effect of group (treatment/genotype) [F(2, 13) = 4.87; p < 0.05] and no group × time interaction. Dunnett tests comparing PCB-treated groups with controls showed that both the Ahr b1 _Cyp1a2 (+/+) and Ahr b1 _Cyp1a2 (-/-) PCB-treated groups exhibited significantly decreased LTP induction compared with untreated Ahr b1 _Cyp1a2 (+/+) controls. *p < 0.05 compared with control averaged across time. (Goldey and Crofton 1998) . In a more recent study, develop mental PCB153 exposure did not affect ASR in Wistar rats (Gralewicz et al. 2009 ). Our finding that PCB alters LTP is consistent with previous findings. We found impaired LTP in the hippocampus (Figure 6 ), as have others (Altmann et al. 2001; Carpenter et al. 2002; Gilbert and Crofton 1999; Gilbert et al. 2000) , which suggests that this region is particularly vulnerable to develop mental PCB exposure.
Alterations in DA in the neostriatum found in the present study have also been reported previously. Coplanar PCB congeners appear to increase DA, whereas non coplanar congeners lead to decreased DA levels (Seegal et al. 1997 ).
Conclusion
Developmental exposure to an environmentally relevant mixture of coplanar and noncoplanar PCBs was associated with learning and memory deficits in genetically susceptible Ahr b1 _Cyp1a2(-/-) mice; in mice having normal basal and inducible CYP1A2 expression, these effects were significantly decreased. In addition, develop mental exposure to AHR agonists appears to improve spatial learning and memory in Ahr b1 _Cyp1a2(+/+) mice in the presence of maternal CYP1A2.
We have generated a novel mouse model for studying genetic susceptibility to PCBinduced neuro toxicity, which is relevant to at-risk human populations. As noted above, humans display > 12-fold variability in AHR affinity and > 60-fold differences in hepatic CYP1A2 basal levels (Nebert et al. 2004) . This means that a highly exposed mother with genetic resistance (i.e., high levels of hepatic CYP1A2, both basal and PCB induced) might have a normal child, whereas a less exposed mother who is genetically susceptible (with low levels of hepatic CYP1A2, both basal and PCB induced) could have a child with develop mental delays despite lower PCB exposure. AHR inducibility influences both hepatic levels of CYP1A2 and clearance of lowermolecular-weight planar and non coplanar PCBs. Therefore, ultimately, the risk of PCBinduced neuro toxicity must account for both CYP1A2 and AHR variability.
